A DNA microarray-based analysis of the host response to a nonviral gene carrier: A strategy for improving the immune response

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1487-1498

  Hatakeyama, Hiroto ^a,b   Ito, Erika ^a   Yamamoto, Momoko ^a   Akita, Hidetaka ^a,b   Hayashi, Yasuhiro ^a   Kajimoto, Kazuaki ^a   Kaji, Noritada ^c   Baba, Yoshinobu ^c   Harashima, Hideyoshi ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 6; LIPID NANOPARTICLE; MACROGOL; MESSENGER RNA; NANOCARRIER; NANOPARTICLE; PEPTIDE; PLASMID DNA; POLYETHYLENEIMINE; PROTEIN GALA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CHEMICAL MODIFICATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA MICROARRAY; DNA MODIFICATION; ENDOSOME; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; MICROARRAY ANALYSIS; MOUSE; MULTIFUNCTIONAL ENVELOPE TYPE NANODEVICE; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PH; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPLEEN; UNINDEXED SEQUENCE; ZETA POTENTIAL;

EID: 79961031809     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.24     Document Type: Article

References (42)

1. Deakin, CT, Alexander, IE and Kerridge, I (2009). Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther 17: 1842-1848.
2. Li, SD and Huang, L (2006). Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13: 1313-1319. (Pubitemid 44323687)
3. Tros de Ilarduya, C, Sun, Y and Düzgünes, N (2010). Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 40: 159-170.
4. Osada, K, Christie, RJ and Kataoka, K (2009). Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J R Soc Interface 6 Suppl 3: S325-S339.
5. Whitmore, M, Li, S and Huang, L (1999). LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 6: 1867-1875. (Pubitemid 29531282)
6. Kawai, T and Akira, S (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
7. Zhao, H, Hemmi, H, Akira, S, Cheng, SH, Scheule, RK and Yew, NS (2004). Contribution of toll-like receptor -9 signaling to the acute inflammatory response to nonviral vectors. Mol Ther 9: 241-248. (Pubitemid 38256550)
8. Sakurai, H, Sakurai, F, Kawabata, K, Sasaki, T, Koizumi, N, Huang, H et al. (2007). Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. J Control Release 117: 430-437. (Pubitemid 46216585)
9. Yasuda, K, Ogawa, Y, Yamane, I, Nishikawa, M and Takakura, Y (2005). Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. J Leukoc Biol 77: 71-79. (Pubitemid 40310695)
10. Takaoka, A, Wang, Z, Choi, MK, Yanai, H, Negishi, H, Ban, T et al. (2007). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505. (Pubitemid 47123520)
11. Yasuda, S, Yoshida, H, Nishikawa, M and Takakura, Y (2010). Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages. Mol Pharm 7: 533-542.
12. Shayakhmetov, DM, Di Paolo, NC and Mossman, KL (2010). Recognition of virus infection and innate host responses to viral gene therapy vectors. Mol Ther 18: 1422-1429.
13. McCaffrey, AP, Fawcett, P, Nakai, H, McCaffrey, RL, Ehrhardt, A, Pham, TT et al. (2008). The host response to adenovirus, helper-dependent adenovirus, and adenoassociated virus in mouse liver. Mol Ther 16: 931-941. (Pubitemid 351587104)
14. Hartman, ZC, Kiang, A, Everett, RS, Serra, D, Yang, XY, Clay, TM et al. (2007). Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J Virol 81: 1796-1812. (Pubitemid 46214453)
15. Hartman, ZC, Black, EP and Amalfitano, A (2007). Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358: 357-372. (Pubitemid 46136424)
16. Omidi, Y, Hollins, AJ, Drayton, RM and Akhtar, S (2005). Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. J Drug Target 13: 431-443. (Pubitemid 43084544)
17. Omidi, Y, Hollins, AJ, Benboubetra, M, Drayton, R, Benter, IF and Akhtar, S (2003). Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectinand oligofectamine-induced gene expression changes in human epithelial cells. J Drug Target 11: 311-323. (Pubitemid 38081335)
18. Tagami, T, Hirose, K, Barichello, JM, Ishida, T and Kiwada, H (2008). Global gene expression profiling in cultured cells is strongly influenced by treatment with siRNAcationic liposome complexes. Pharm Res 25: 2497-2504.
19. Beyerle, A, Irmler, M, Beckers, J, Kissel, T and Stoeger, T (2010). Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications. Mol Pharm 7: 727-737.
20. Kogure, K, Akita, H, Yamada, Y and Harashima, H (2008). Multifunctional envelopetype nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 60: 559-571. (Pubitemid 351215573)
21. Cesta, MF (2006). Normal structure, function, and histology of the spleen. Toxicol Pathol 34: 455-465. (Pubitemid 44652213)
22. Alexis, F, Pridgen, E, Molnar, LK and Farokhzad, OC (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5: 505-515.
23. Hafez, IM and Cullis, PR (2001). Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev 47: 139-148. (Pubitemid 32324111)
24. Mishra, S, Webster, P and Davis, ME (2004). PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 83: 97-111. (Pubitemid 38765217)
25. Remaut, K, Lucas, B, Braeckmans, K, Demeester, J and De Smedt, SC (2007). Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J Control Release 117: 256-266. (Pubitemid 46161877)
26. Sasaki, K, Kogure, K, Chaki, S, Nakamura, Y, Moriguchi, R, Hamada, H et al. (2008). An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 391: 2717-2727.
27. Sakurai, Y, Hatakeyama, H, Akita, H, Oishi, M, Nagasaki, Y, Futaki, S et al. (2009). Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system. Biol Pharm Bull 32: 928-932.
28. Hatakeyama, H, Ito, E, Akita, H, Oishi, M, Nagasaki, Y, Futaki, S et al. (2009). A pHsensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release 139: 127-132.
29. Li, W, Nicol, F and Szoka, FC Jr (2004). GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 56: 967-985. (Pubitemid 38520204)
30. Kawakami, S, Ito, Y, Charoensit, P, Yamashita, F and Hashida, M (2006). Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther 317: 1382-1390. (Pubitemid 43764145)
31. Saito, Y, Higuchi, Y, Kawakami, S, Yamashita, F and Hashida, M (2009). Immunostimulatory characteristics induced by linear polyethyleneimineplasmid DNA complexes in cultured macrophages. Hum Gene Ther 20: 137-145.
32. Freudenberg, MA, Tchaptchet, S, Keck, S, Fejer, G, Huber, M, Schütze, N et al. (2008). Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 213: 193-203.
33. Botero, TM, Shelburne, CE, Holland, GR, Hanks, CT and Nör, JE (2006). TLR4 mediates LPS-induced VEGF expression in odontoblasts. J Endod 32: 951-955. (Pubitemid 44374725)
34. Pedron, T, Girard, R, Inoue, K, Charon, D and Chaby, R (1997). Lipopolysaccharide and the glycoside ring of staurosporine induce CD14 expression on bone marrow granulocytes by different mechanisms. Mol Pharmacol 52: 692-700. (Pubitemid 27443992)
35. Tanaka, T, Legat, A, Adam, E, Steuve, J, Gatot, JS, Vandenbranden, M et al. (2008). DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. Eur J Immunol 38: 1351-1357.
36. Kedmi, R, Ben-Arie, N and Peer, D (2010). The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials 31: 6867-6875.
37. Kakudo, T, Chaki, S, Futaki, S, Nakase, I, Akaji, K, Kawakami, T et al. (2004). Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43: 5618-5628. (Pubitemid 38623596)
38. Li, W, Huang, Z, MacKay, JA, Grube, S and Szoka, FC Jr (2005). Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J Gene Med 7: 67-79.
39. Shin, J, Shum, P and Thompson, DH (2003). Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release 91: 187-200. (Pubitemid 37288890)
40. Zalipsky, S, Qazen, M, Walker, JA 2nd, Mullah, N, Quinn, YP and Huang, SK (1999). New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem 10: 703-707. (Pubitemid 29456355)
41. Zhang, JX, Zalipsky, S, Mullah, N, Pechar, M and Allen, TM (2004). Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers. Pharmacol Res 49: 185-198. (Pubitemid 37485715)
42. Hatakeyama, H, Akita, H, Kogure, K, Oishi, M, Nagasaki, Y, Kihira, Y et al. (2007). Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 14: 68-77. (Pubitemid 44942867)